Company: CORT
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001628280-25-037005
Chunk: 247

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 3
Chunk 247
---
ited Condensed Consolidated Statements of Comprehensive Income for the three and six month periods ended June 30, 2025 and 2024, (iv) Unaudited Condensed Consolidated Statements of Cash Flows for the six month periods ended June 30, 2025 and 2024, (v) Unaudited Condensed Consolidated Statement of Stockholders’ Equity and (vi) Notes to Unaudited Condensed Consolidated Financial Statements.104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

43

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 CORCEPT THERAPEUTICS INCORPORATED  Date: July 31, 2025/s/ Joseph K. Belanoff Joseph K. Belanoff, M.D.Chief Executive Officer  Date: July 31, 2025/s/Atabak Mokari Atabak Mokari Chief Financial OfficerDate:July 31, 2025/s/Joseph D. LyonJoseph D. LyonChief Accounting & Technology Officer

44